Literature DB >> 10731588

Jumping translocations of 11q in acute myeloid leukemia and 1q in follicular lymphoma.

Y S Fan1, K Rizkalla, B F William, C J Engel.   

Abstract

Jumping translocation is a rare cytogenetic aberration in leukemia and lymphoma, and its etiologic mechanisms are not clearly known. We report two cases with jumping translocations. One had follicular lymphoma and jumping translocations of 1q onto the telomeric regions of 5p, 9p, and 15q in three cell lines, co-existing with the specific translocation t(14;18)(q32;q21). The second case had acute myeloid leukemia (AML) and jumping translocations of 11q as the sole aberration, onto multiple derivative chromosomes in each of the abnormal cells. A total of 17 telomeric regions were seen as the recipients of 11q in this case, and 9q was always involved as one of the recipients in all abnormal cells. Fluorescence in situ hybridization (FISH) confirmed the identification of 11q material in the derivative chromosomes. While 1q has been the most common donor of acquired jumping translocations, this is the first report on jumping translocations of 11q. Different from all previously reported jumping translocations which involve only one recipient in each cell line and lead to a mosaic trisomy, multiple recipients in most of the abnormal cells in this case had led to a tetrasomy, or a pentasomy of 11q. The pattern of chromosome involvement as the recipients of 11q appears to show a continuing evolutionary process of jumping, stabilization, and spreading of the donor material into other chromosomes. Somatic recombinations between the interstitial telomeric or subtelomeric sequences of a derivative chromosome and the telomeric sequences of normal chromosomes are believed to be the underlying mechanism of jumping translocations and their clonal evolution.

Entities:  

Mesh:

Year:  2000        PMID: 10731588     DOI: 10.1016/s0165-4608(99)00149-1

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  5 in total

1.  Jumping translocations, a novel finding in chronic lymphocytic leukaemia.

Authors:  Cecelia R Miller; Deborah Stephens; Amy S Ruppert; Frederick Racke; Andrew McFaddin; Heather Breidenbach; Huey-Jen Lin; Kathy Waller; Tammy Bannerman; Jeffrey A Jones; Jennifer A Woyach; Leslie A Andritsos; Kami Maddocks; Weiqiang Zhao; Gerard Lozanski; Joseph M Flynn; Michael Grever; John C Byrd; Nyla A Heerema
Journal:  Br J Haematol       Date:  2015-04-19       Impact factor: 6.998

2.  Jumping Translocations in Myeloid Malignancies Associated With Treatment Resistance and Poor Survival.

Authors:  David Sanford; Courtney D DiNardo; Guilin Tang; Jorge E Cortes; Srdan Verstovsek; Elias Jabbour; Farhad Ravandi; Hagop Kantarjian; Guillermo Garcia-Manero
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2015-06-06

3.  Jumping translocation in acute monocytic leukemia (M5b) with alternative breakpoint sites in the long arm of donor chromosome 3.

Authors:  Peter McGrattan; Amy Logan; Mervyn Humphreys; Margaret Bowers
Journal:  Med Oncol       Date:  2009-07-22       Impact factor: 3.064

4.  Unbalanced jumping translocation involving 3q in myeloproliferative disease.

Authors:  Peter McGrattan; Mervyn Humphreys; Donald Hull
Journal:  Med Oncol       Date:  2008-05-29       Impact factor: 3.064

5.  Maintenance and characterization of an Epstein Barr virus-infected CD56-negative T cell lymphoma.

Authors:  Izuru Maekawa; Hitoshi Satoh; Naoto Aoki; Yasuyuki Morishita; Norifumi Tsukamoto; Masamitsu Karasawa; Yasunobu Nonaka; Mami Shiota; Yoshihisa Nojima; Shigeo Mori
Journal:  Jpn J Cancer Res       Date:  2002-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.